The Impact of Low Versus High Positive End-expiratory Pressure on Diaphragm Function, Ventilation Efficiency, and Lung Mechanics
Key facts
- Who runs it
- Vastra Gotaland Region
- Where
- Sweden2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 25 people, planned
- Started
- 31 Aug 2026
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 3 groups
- Treatments tested
- Low positive end-expiratory pressure
- Medium positive end-expiratory pressure
- High positive end-expiratory pressure
- Record updated
- 2 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Mechanical ventilation with pressure support or mechanical ventilation with possibility to transition to pressure support
- Oxygen requirement ≤ 50%
- Pressure support ≤ 12 cmH2O
- PEEP ≤ 12 cmH2O
- Age ≥ 18 years
- Adequate intravascular volume status
Who cannot take part
- Conditions with increased risk of pneumothorax (such as severe COPD (Chronic Obstructive Pulmonary Disease) or extensive emphysema)
- Heart rate > 120 beats/min
- Circulatory instability
- Brain death diagnosis/brain death evaluation
- Norepinephrine dose > 0.4 µg/kg/min
- Muscle relaxation administered within 2 hours
- Pregnancy
- Contraindication to esophageal catheterization (e.g., esophageal varices)
- Untreated pneumothorax
- Symptomatic airway obstruction; Discontinuation criteria during ongoing study intervention:
- Systolic blood pressure > 180 mmHg
- Inspired oxygen fraction > 70%
- Respiratory rate > 35/min
- RASS (Richmond Agitation Sedation Scale) ≥ 2
- Doubling of norepinephrine dose or increase of norepinephrine dose to > 0.5 µg/kg/min to maintain mean arterial pressure
- Bradycardia < 45 beats/min
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this interventional study is to evaluate the effect of different positive end-expiratory pressures (PEEP) on lung and diaphragm function in patients mechanically ventilated with pressure support ventilation in the intensive care unit. The main questions aim to answer:
Read full original descriptionShow less
Does higher PEEP level affect diaphragm contractions and ventilatory efficiency? Does higher PEEP level limit inspiratory efforts? Does higher PEEP level affect lung compliance?
The participants will be subjected to three different PEEP levels during pressure support ventilation:
Low PEEP (4 cmH2O), Medium PEEP (10 cmH2O), High PEEP (16 cmH2O).
The lung and diaphragm function will be evaluated using high-resolution esophageal manometry, electrical activity of the diaphragm, external diaphragm ultrasound and spirometric ventilator data.
The 3 groups in the trial
- Low PEEPTreatment being tested
Low positive end-expiratory pressure (4 cmH2O)
Treatment: Low positive end-expiratory pressure
- Medium PEEPTreatment being tested
Medium positive end-expiratory pressure (10 cmH2O)
Treatment: Medium positive end-expiratory pressure
- High PEEPTreatment being tested
High positive end-expiratory pressure (16 cmH2O)
Treatment: High positive end-expiratory pressure
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Impact of Low Versus High Positive End-Expiratory Pressure on Diaphragm Function, Ventilation Efficiency, and Lung Mechanics During Pressure Support Ventilation: A Randomized Interventional Crossover Study
- Record updated
- 2 September 2026